Of note, many reports have also shown an association between PD-L1 expression and poor prognosis for patients with different solid tumors, including hepatocellular carcinoma [59], breast cancer [60], and oral squamous cell carcinoma [61]. This evidence concerns the gene CD274 and breast cancer.